Maizinol + Affron
Natural health product licensed in Canada
- Other names
- Advanced Stress Manager, Advanced Stress Release, Advanced Stress Support, REMZen, SereneSleep
- Licence holder
- Advanced Orthomolecular Research Inc.
- NPN or DIN-HM
- 80140269
- Status
- Active licence
- Licence date
- 16 April 2025
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zea mays Source : Zea mays - Feuille Extract : Matériel brut sec Extraction ratio : 60:1 Dry plant equivalent : 15,000 mg | Not specified | Not calculated |
| Crocus sativus Source : Crocus sativus - Stigmate Extract : Matériel brut sec Extraction ratio : 3:1 Dry plant equivalent : 42 mg Potency : 3.48 % Crocin | 14 mg | Not calculated |
| Zea mays Source : Zea mays - Feuille Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 12,500 mg Potency : 0.2 % 6-Methoxybenzoxazolinone | 250 mg | Not calculated |
| Crocus sativus Source : Crocus sativus - Stigmate Potency : 0.03 % 2,6,6-Trimethylcyclohexa-1,3-diene-1-carbaldehyde | Not specified | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Maltodextrine, Hypromellose, Stéaryl fumarate de sodium, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 2 Tous les jours |
| Adultes | minimum: 18 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Maizinol Helps to reduce cortisol levels, a biomarker of physical stress. Helps to support better sleep quality. Provides antioxidants. Helps support a healthy mood balance. Affron® helps to relieve restlessness and/or nervousness (calmative), supports positive effects on symptoms of perceived stress such as, fatigue, weariness, and irritability, helps to reduce the symptoms of perceived stress, such as fatigue, weariness, and irritability. Helps to improve restorative sleep, in individuals experiencing sleeplessness, helps improve sleep quality in individuals experiencing sleeplessness. Supports the management of symptoms associated with perimenopause. Clinically proven to help improve sleep quality in 4 weeks. May help to support healthy mood balance during perimenopause. Helps to support healthy mood balance during perimenopause. Clinically shown to help relieve symptoms associated with perimenopause. Helps to support mood balance after awakening.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80140269
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.